Telecoaching program to increase physical activity after lung cancer surgery
Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer: a Randomized Controlled Trial
This study is testing a 12-week telecoaching program to see if it can help people who have had lung cancer surgery become more active and improve their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Ghent Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 6 sites (Genk, Limburg and 5 other locations) |
| Trial ID | NCT06057766 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a 12-week telecoaching program designed to enhance physical activity in patients who have undergone surgery for resectable non-small cell lung cancer (NSCLC). Participants will be randomly assigned to either the intervention group, which receives telecoaching and a wearable device to track their daily steps, or the control group receiving usual care. The study aims to assess the effectiveness and acceptability of this program in improving physical activity levels among patients recovering from lung surgery. The trial will enroll patients from one month to one year post-surgery.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have undergone surgery for resectable stage I-IIIA NSCLC and are not currently engaged in structured exercise.
Not a fit: Patients with progressive or recurrent lung cancer or those with psychiatric disorders that prevent participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the physical activity levels and quality of life for patients recovering from lung cancer surgery.
How similar studies have performed: Previous studies have indicated benefits of physical activity interventions in lung cancer survivors, suggesting potential success for this telecoaching approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Resectable (I-IIIA) NSCLC patients who had lung resection surgery, one to twelve months before inclusion, with or without (neo-)adjuvant chemotherapy/radiotherapy/immunotherapy. * If patients received adjuvant chemotherapy/radiotherapy, the inclusion window is one months to twelve months after the end of adjuvant chemotherapy/radiotherapy. * If patients receive adjuvant immunotherapy after the end of adjuvant chemotherapy, patients can be included during the immunotherapy. * Adults (18+ year) * Patients who do not systematically perform structured exercise or are planned to do so. * Ability to give informed consent Exclusion Criteria: * Patients having progressive or recurrent lung cancer * Patients who had other malignancies in the last 2 years * Psychiatric disorders that preclude them from participation in a physical activity intervention and/or performing the test battery * Unable to learn to work with a new electronic device (e.g. smartphone) * Not understanding and speaking Dutch * Patients with comorbidities or other treatments that preclude them from participation in a physical activity intervention and/or performing the test battery
Where this trial is running
Genk, Limburg and 5 other locations
- Ziekenhuis Oost-Limburg — Genk, Limburg, Belgium (Recruiting)
- Hasselt University — Hasselt, Limburg, Belgium (Recruiting)
- Jessa Ziekenhuis — Hasselt, Limburg, Belgium (Not_yet_recruiting)
- Ghent University Hospital — Ghent, Oost-Vlaanderen, Belgium (Recruiting)
- AZ Sint-Jan — Bruges, West-Vlaanderen, Belgium (Recruiting)
- AZ Delta — Roeselare, West-Vlaanderen, Belgium (Recruiting)
Study contacts
- Principal investigator: Dieter Stevens, MD — University Hospital, Ghent
- Study coordinator: Eva Arents, MSc
- Email: eva.arents@ugent.be
- Phone: 003293320528
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.